Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized …
L Xu, L Wang, K Li, Z Zhang, H Sun… - Drug Design …, 2019 - Taylor & Francis
Background: Nicorandil prior to reperfusion by primary percutaneous coronary intervention
(PCI) in patients with ST-segment elevated myocardial infarction (STEMI) has been …
(PCI) in patients with ST-segment elevated myocardial infarction (STEMI) has been …
The effects of dapagliflozin in patients with heart failure complicated with type 2 diabetes: a meta-analysis of placebo-controlled randomized trials
M Zhai, X Du, C Liu, H Xu - Frontiers in Clinical Diabetes and …, 2021 - frontiersin.org
Background Cardiovascular disease threatens the health and quality of life of individuals,
particularly those with type II diabetes. Recently, some studies have reported the effect of …
particularly those with type II diabetes. Recently, some studies have reported the effect of …
Cardiovascular events associated with nicorandil administration prior to primary percutaneous coronary intervention in patients with acute ST-segment elevated …
J Li, X Xu, X Zhou, J Dai, L Ma, C Chen… - Expert Opinion on …, 2019 - Taylor & Francis
Introduction: Nicorandil may exert cardioprotective effects in ischemic heart disease.
However, its efficacy in combination with early reperfusion is uncertain. The authors …
However, its efficacy in combination with early reperfusion is uncertain. The authors …
[HTML][HTML] Use of nicorandil is associated with increased risk of incident atrial fibrillation
Background: Nicorandil will activate ATP-sensitive potassium channel (KATP). However,
activation of potassium channels plays an important role in the mechanism of atrial …
activation of potassium channels plays an important role in the mechanism of atrial …
Reduction in the incidence of myocardial infarction with sodium–glucose linked cotransporter-2 inhibitors: evident and plausible
RE Gilbert, KA Connelly - Cardiovascular Diabetology, 2019 - Springer
While able to reduce hospitalization for heart failure, kidney disease progression and
cardiovascular death, sodium–glucose linked cotransporter-2 (SGLT2) inhibitors are not …
cardiovascular death, sodium–glucose linked cotransporter-2 (SGLT2) inhibitors are not …
The Efficacy and Safety of Nicorandil for Periprocedural Myocardial Injury in Patients Undergoing PCI: A Meta‐Analysis
Y Lu, W Hu, Q Song, Q Wang - Journal of Interventional …, 2020 - Wiley Online Library
Purpose. To evaluate the efficacy and safety of nicorandil for periprocedural myocardial
injury in patients undergoing PCI through meta‐analysis of randomized controlled trials …
injury in patients undergoing PCI through meta‐analysis of randomized controlled trials …
[PDF][PDF] 冠心舒通胶囊联合尼可地尔对冠心病稳定型心绞痛心血瘀阻型患者心功能, 血液流变学和炎症因子的影响
潘玲， 李萍， 欧阳书堃， 宋惠… - Progress in Modern …, 2022 - biomed.cnjournals.com
摘要目的: 观察冠心舒通胶囊联合尼可地尔在冠心病稳定型心绞痛心血瘀阻型患者中的应用价值
. 方法: 根据随机数字表法, 将广州中医药大学附属重庆北碚中医院2021 年1 月~ 2021 年12 …
. 方法: 根据随机数字表法, 将广州中医药大学附属重庆北碚中医院2021 年1 月~ 2021 年12 …
Nicorandil for periprocedural myocardial injury in elective percutaneous coronary intervention: a meta-analysis of 10 randomized controlled trials
B Yi, J Luo, Y Jiang, S Mo, X Xiao, X Chen… - Angiology, 2020 - journals.sagepub.com
The clinical outcomes of nicorandil in percutaneous coronary intervention (PCI) are
conflicting. We sought to evaluate the effects of nicorandil on periprocedural myocardial …
conflicting. We sought to evaluate the effects of nicorandil on periprocedural myocardial …
[PDF][PDF] 冠心病患者经皮冠状动脉介入治疗术后支架内再狭窄的相关危险因素分析
罗江宾， 王天松， 何喜民， 冯旭霞， 陈其敬… - 现代生物医学 …, 2019 - biomed.cnjournals.com
摘要目的: 探究冠心病(CHD) 患者经皮冠状动脉介入治疗(PCI) 术后支架内再狭窄(ISR)
的相关危险因素. 方法: 选取2014 年6 月~ 2017 年6 月期间我院收治的行PCI 的CHD 患者200 …
的相关危险因素. 方法: 选取2014 年6 月~ 2017 年6 月期间我院收治的行PCI 的CHD 患者200 …
[图书][B] Reporting of Financial Conflicts of Interest of Pharmacological Treatment Trials in Cochrane and non-Cochrane Meta-analyses: A Cross-sectional Study
KA Turner - 2019 - search.proquest.com
Background: Previous studies have found that meta-analyses often fail to report financial
conflicts of interest (FCOIs) from included randomized controlled trials (RCTs). A 2011 study …
conflicts of interest (FCOIs) from included randomized controlled trials (RCTs). A 2011 study …